Cargando…

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020

Background: Carbapenemase genes in carbapenem-resistant Enterobacterales (CP-CRE) may be transmitted between patients and bacteria. Reported rates of carbapenemase genes vary widely, and it is unclear whether having a carbapenemase gene portends worse outcomes given that all patients with CRE infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witt, Lucy, Babike, Ahmed, Smith, Gillian, Satola, Sarah, Sexton, Mary Elizabeth, Jacob, Jesse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Mdr Gnr
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594119/ http://dx.doi.org/10.1017/ash.2023.226

Ejemplares similares

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Identifying patients at high risk for carbapenem-resistant Enterobacterales carriage upon admission to acute-care hospitals
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)

Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates and evaluation of hospital-acquired infections
por: Ajaka, Leama, et al.
Publicado: (2023)

Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis
por: Monk, Miranda, et al.
Publicado: (2023)

Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in hospitalized patients in Botswana
por: Mannathoko, Naledi Betsi, et al.
Publicado: (2023)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

Characteristics of patients positive for COVID-19 and multidrug-resistant organisms in Tennessee, 2020–2021
por: Stover, Carolyn, et al.
Publicado: (2022)

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients
por: Landmesser, Katherine, et al.
Publicado: (2021)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

How Does Antimicrobial Resistance Increase Medical Costs in Community-Acquired Acute Pyelonephritis?
por: Kim, Bongyoung, et al.
Publicado: (2021)

Stewardship Nightmare: Ceftolozane/Tazobactam–Resistant Pseudomonas aeruginosa Infections Accelerated by the COVID-19 Pandemic
por: Haviland, Adam, et al.
Publicado: (2021)

Management of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes
por: Ramanathan, Swetha, et al.
Publicado: (2021)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)–producing Enterobacaterales and Candida auris
por: Greco, Christian, et al.
Publicado: (2022)

Low function and frequent readmission in nursing home patients with persistent resistant gram-negative bacterial colonization
por: Mills, John, et al.
Publicado: (2022)

A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital
por: Vasudeva, Shikha, et al.
Publicado: (2022)

Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
por: Cincotta, Samuel, et al.
Publicado: (2022)

Real-world clinical outcomes of cefiderocol therapy in the Veterans Health Administration, 2019–2022
por: Amenta, Eva, et al.
Publicado: (2023)

416. Evaluating Indwelling Devices and Mortality in Invasive Carbapenem-Resistant Enterobacterales Infections, Atlanta, GA, 2012–2019.
por: Witt, Lucy S, et al.
Publicado: (2022)

506. Urinary Catheters Are Associated with Progression from Bacteriuria to Invasive Infections in Patients with Carbapenem-Resistant Enterobacteriaceae, Metropolitan Atlanta, 2011–2017
por: Howard-Anderson, Jessica, et al.
Publicado: (2019)

787. Clinical and Genomic Epidemiology of mcr-9 Containing Carbapenem-resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012-2017
por: Babiker, Ahmed, et al.
Publicado: (2021)

Clinical and Genomic Epidemiology of mcr-9-Carrying Carbapenem-Resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012 to 2017
por: Babiker, Ahmed, et al.
Publicado: (2022)

SG-APSIC1097: The impact of COVID-19 on the incidence of carbapenem-resistant Enterobacterales (CRE) in Singapore: An interrupted time-series analysis
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
por: Wu, Tuodi, et al.
Publicado: (2023)

SG-APSIC1203: Detection of carbapenemase genes in donor lungs at the point of care before transplantation reduces the risk of carbapenem-resistant Enterobacteriaceae–associated donor-derived infection in lung-transplant recipients
por: Zhou, Wenyong, et al.
Publicado: (2023)

Comparison of 30- and 90-Day Mortality Rates in Patients with Cultures Positive for Carbapenem-resistant Enterobacteriaceae and Acinetobacter in Atlanta, 2011–2015
por: Sexton, Mary Elizabeth, et al.
Publicado: (2017)

834. Clinical Outcomes with Carbapenem-Resistant Pseudomonas aeruginosa that Retain Susceptibility to Traditional Antipseudomonal β-lactams: Atlanta, 2016-2018
por: Howard-Anderson, Jessica, et al.
Publicado: (2020)

Substantial Overlap Between Incarceration and Tuberculosis in Atlanta, Georgia, 2011
por: Haddad, Maryam B., et al.
Publicado: (2014)

Atlanta, Georgia
por: Catching, B. H.
Publicado: (1890)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
por: Black, Cody A., et al.
Publicado: (2021)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
por: Wielders, Cornelia C. H., et al.
Publicado: (2022)

SG-APSIC1199: Evaluation of a pooling strategy using Xpert Carba-R assay for screening for carbapenemase-producing organisms in rectal swabs
por: Zhang, Peng, et al.
Publicado: (2023)

SG-APSIC1083: Prevalence and classification of carbapenemase-producing gram-negative bacilli at a medical center in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

SG-APSIC1157: The attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections—A prospective cohort study in Suva, Fiji
por: Loftus, Michael, et al.
Publicado: (2023)

SG-APSIC1095: Acquisition rate of carbapenemase-producing organisms (CPOs) among hospital contacts of CPO patients: An interim subgroup analysis of a cohort study
por: Husen, Sharifah Farhanah Syed, et al.
Publicado: (2023)

Diseases of Atlanta, Georgia
por: Westmoreland, J. G.
Publicado: (1856)

SG-APSIC1080: Surveillance and control efforts for carbapenemase-producing gram-negative bacteria at a high-burden tertiary-care healthcare facility in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

SG-APSIC1123: Diagnostic and infection prevention and control (IPC) performance of rapid polymerase chain reaction (PCR) compared to conventional culture PCR methods for detecting carbapenemase-producing organisms (CPOs)
por: Huan, Xiaowei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r6crrj2hu94e1e2b0j7g7tpg80